Search - tctmd.com

Displaying 241 - 260 of 290

Sort: Relevancy | Date

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Daily News

年度回顾：医生成为2013年最重要介入新闻主角

Yael L. Maxwell

January 27, 2014

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

Yael L. Maxwell

January 27, 2014

News Daily News

Watchman获得FDA顾问小组的实质认可

Yael L. Maxwell

January 01, 2014

News Daily News

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Yael L. Maxwell

January 01, 2014

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Daily News

心房纤维颤动患者封堵装置血栓形成风险因素已被确认

Yael L. Maxwell

June 28, 2013

News Daily News

Risk Factors for Thrombus Formation on Cardiac Plug in A-fib Patients Identified

Yael L. Maxwell

June 28, 2013

News Daily News

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

Yael L. Maxwell

June 28, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

L.A. McKeown

May 28, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Industry News

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

May 17, 2013

News Industry News

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

May 09, 2013

News Daily News

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Yael L. Maxwell

April 12, 2013

Advertisement

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

年度回顾：医生成为2013年最重要介入新闻主角

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

Watchman获得FDA顾问小组的实质认可

Watchman Wins Substantial Endorsement from FDA Advisory Panel

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Experts Discuss Efficacy, Safety of Watchman Device

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

心房纤维颤动患者封堵装置血栓形成风险因素已被确认

Risk Factors for Thrombus Formation on Cardiac Plug in A-fib Patients Identified

Identificados los Factores de Riesgo para la Formación de Trombos asociados a los Dispositivos Oclusores Cardíacos en Pacientes con FA

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content